Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study.
Hideki IshidaNorihiko GotoRyoichi ImamuraHajime SasakiKohei UnagamiKenta FutamuraYoshihiko MurataNobuyuki OshimaToshiko EtoBarbara HaberPublished in: Clinical and experimental nephrology (2024)
ClinicalTrials.gov NCT04129398.